CYTK · Cytokinetics Inc
United States · RS rating 28 · As of 2026-10-14
| Price | 63.43 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 26 / 18 / 56 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 42 / 21 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +41.2% |
| Sales growth Q/Q | +817.1% |
| Distance from 52-week high | +27.3% |
| Market cap (USD) | $8.1B |